Infectious Disease Treatments Market to Foresee Growth with an Estimated CAGR of ~7.1% by 2023

By , in PR PR Health on .

Pune, India — 02/14/2018 — adds “Infectious Disease Treatments Market -2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.


The intense need for in-depth understanding of the “Infectious Disease Treatments Market -Forecast to 2023? coupled with its high growth potential necessitated the development of this report by Market Research Future. The report specifically focuses on the key industry development trends and forces that shapes the market, but not limited to only commercial nature, but which encompasses a broad range such as social, technological and others. The global infectious disease treatments market is expected to grow at an approximate CAGR of 7.1% during the forecast period.

Regional Analysis:
The Americas dominate the global infectious disease treatments market owing to a well-developed healthcare sector and huge patient population. Moreover, increasing healthcare expenditure followed by changing lifestyle drives the market growth in the Americas.

Europe is the second largest infectious disease treatments market. High healthcare expenditures, government support for research & development, and huge patient population drives the European market.

Asia Pacific is the fastest growing region in the global market due to the presence of a huge patient population and continuously developing economies like India and China. On the other hand, the Middle East & Africa holds the least share in the global infectious disease treatments market due to the presence of poor economies in the African region. A majority of the Middle East & Africa market is held by the Middle East.

Key Players:
Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Novartis AG (Switzerland), Sanofi (France), Mylan N.V. (U.S.), and others are some of the key players for the global infectious disease treatments market.

Market Highlights:
Infectious diseases can be caused by bacteria, viruses, fungi, and parasites. Some of the common examples of infectious diseases are acquired immunodeficiency syndrome (AIDS), hepatitis B, tuberculosis (TB), and others. Increasing prevalence of the infectious diseases like TB, AIDS is one of the major drivers for the growth of the market during the forecast period. According to the World Health Organization, in 2016, HIV/AIDS affected 36.7 million people, causing 1.0 million deaths across the globe. Additionally, increasing healthcare expenditures and growing awareness of infectious diseases among the patients will boost the market growth during the forecast period. However, low adoption of the treatment and low per capita healthcare expenditure in the developing economies may restrain the market growth during the forecast period.

ACCESS COMPLETE [email protected] .

The global infectious disease treatments market is segmented on the basis of type, treatment, and end-users.

On the basis of the type, the market is segmented into viral diseases, bacterial diseases, and others. The viral diseases segment is sub-segmented into acquired immunodeficiency syndrome (AIDS), hepatitis B, hepatitis C, and others. The bacterial diseases segment is sub-segmented into tuberculosis (TB), bacterial meningitis, and others.

On the basis of the treatment, the market is segmented into antibacterial drugs, antifungal drugs, antiviral drugs, anti-parasitic drugs, and others. The antibacterial drugs segment is sub-segmented into beta-lactams, quinolones, sulfonamides, tetracyclines, and others. The antifungal drugs segment is sub-segmented into azoles, pyrimidines, echinodians, polyenes, and others.

On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, research organization, retail pharmacies, and others.

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Treatment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis



About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]

The following two tabs change content below.
Jasmine Petters

Jasmine Petters

Jasmine hails from the city of Nizams, Hyderabad, and is currently pursuing her M.D. from there only. She is an internet wizard and has keen passion in All Things tech. She is a regular Comment contributor for The Daily Telescope and writes a Web column, in which she covers war, sports, and everything in between.
%d bloggers like this: